Victory Capital Management Inc Harvard Bioscience Inc Transaction History

Victory Capital Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$4.0 - $5.49 $3,820 - $5,242	955 Added 5.59%	18,047 $96,000
Q4 2022 Feb 09, 2023	BUY	$2.12 - $2.86 $9,046 - $12,203	4,267 Added 33.27%	17,092 $47,000
Q3 2022 Nov 02, 2022	BUY	$2.33 - $3.92 $1,248 - $2,101	536 Added 4.36%	12,825 $33,000
Q2 2022 Aug 01, 2022	SELL	$3.28 - $6.42 $1,328 - $2,600	-405 Reduced 3.19%	12,289 $44,000
Q1 2022 May 04, 2022	SELL	$5.16 - $7.14 $1,099 - $1,520	-213 Reduced 1.65%	12,694 $79,000
Q4 2021 Feb 07, 2022	SELL	$6.37 - $8.18 $2,242 - $2,879	-352 Reduced 2.65%	12,907 $91,000
Q3 2021 Nov 02, 2021	BUY	$6.98 - $8.47 $1,026 - $1,245	147 Added 1.12%	13,259 $93,000
Q2 2021 Aug 03, 2021	SELL	$5.44 - $8.4 $70,110 - $108,259	-12,888 Reduced 49.57%	13,112 $109,000
Q1 2021 May 04, 2021	BUY	$3.91 - $6.99 $101,660 - $181,740	26,000 New	26,000 $142,000
Q2 2020 Aug 07, 2020	SELL	$2.12 - $3.14 $12,999 - $19,254	-6,132 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.42 - $3.29 $197 - $457	-139 Reduced 2.22%	6,132 $14,000
Q4 2019 Feb 04, 2020	BUY	$2.45 - $3.25 $4,059 - $5,385	1,657 Added 35.91%	6,271 $19,000
Q3 2019 Nov 12, 2019	BUY	$1.59 - $3.47 $7,336 - $16,010	4,614 New	4,614 $14,000

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.